fbpx

Day

oktober 23, 2018
23RD OCTOBER 2018 EB8018, the lead investigational candidate, targets Crohn’s disease with potential for other GI disorders Paris, France and Cambridge, MA, USA – October 23, 2018 ENTEROME SA, a clinical-stage biotech company developing innovative therapies to treat microbiome-associated diseases with a focus on auto-immune disease and cancer, has entered into a global licensing, co-development and co-promotion...
Palma, Spain and San Diego, USA, 23 October, 2018 – Laboratoris Sanifit S.L., a clinical-stage biopharmaceutical company focused on treatments for calcification disorders, today announces that data from a phase I study assessing the safety and tolerability of its lead drug candidate SNF472 in haemodialysis patients has been published in the British Journal of Clinical...
Et hold forskere på Københavns Universitet har ved at arbejde med myrehjerner identificeret helt basale DNA-netværk, der med stor sandsynlighed kan siges at styre hjerneaktivitet. Opdagelsen er netop offentliggjort i det videnskabelige tidsskrift Nature Ecology and Evolution. Metoden kan bruges til at udforske sammenhænge mellem generelle hjernefunktioner og social adfærd. Hvilke gener skal tændes og...

Nyheder

Lundbeckfonden udvider ledelsen med to stærke profiler
8. august 2019
Event: Fra trip til koma – bliv klogere på din bevidsthed
6. august 2019
Lymfekræft i huden kunne holdes nede med antibiotika 
25. juli 2019

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge